AS100 - Moligand™, ≥98% , Antagonist of A 1 receptor;Antagonist of A 2B receptor, CAS No.860033-28-9, Antagonist of A 1 receptor;Antagonist of A 2B receptor

CAS: 860033-28-9 Cat. No.: A607750 Formule: C23H24Cl3N7O4 Poids moléculaire: 568.84
DISPONIBLE À COMMANDE
QUALITÉ & PURETÉ Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Taille
USA
Allemagne (EU)*
Prix
Qté
5mg
A607750-5mg
Sur commande · 8–12 semaines
1 285,90$US
10mg
A607750-10mg
Sur commande · 8–12 semaines
1 399,90$US
25mg
A607750-25mg
Sur commande · 8–12 semaines
3 053,90$US
Enter a quantity for the sizes you want to add.

Vue d’ensemble

AS100 is a bioactive chemical.

Spécifications

Spécifications et pureté
Moligand™, ≥98%
Conditions de stockage de stockage
Store at -20°C
Expédié en
Ice chest + Ice pads
Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.
Grade
Moligand™
Type d'action
ANTAGONIST
Mécanisme d'action
Antagonist of A 1 receptor;Antagonist of A 2B receptor
Pureté
≥98%
Noms et identifiants
SMILES
CCCn1c2[nH]c(nc2c(=O)n(c1=O)CCC)c1cc(nn1C)OCC(=O)Nc1ccc(c(c1)Cl)Cl
IUPAC Name
N-(3,4-dichlorophenyl)-2-{[5-(2,6-dioxo-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purin-8-yl)-1-methyl-1H-pyrazol-3-yl]oxy}acetamide
InChIKey
OESRCCUPNGDTIR-UHFFFAOYSA-N
InChI
1S/C23H25Cl2N7O4/c1-4-8-31-21-19(22(34)32(9-5-2)23(31)35)27-20(28-21)16-11-18(29-30(16)3)36-12-17(33)26-13-6-7-14(24)15(25)10-13/h6-7,10-11H,4-5,8-9,12H2,1-3H3,(H,26,33)(H,27,28)
Isomères SMILES
CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C3=CC(=NN3C)OCC(=O)NC4=CC(=C(C=C4)Cl)Cl
Poids moléculaire
568.84
Reaxys
9675454
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=9675454&ln=

Données avancées

Structure 3D
Modèle de structure chimique interactif





Cibles associées (humaines)
ADORA2B Tclin Adenosine receptor A2b (4 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA1 Tclin Adenosine receptor A1 (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2B Tclin Adenosine A2b receptor (7672 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2B Tclin Adenosine receptors; A2b & A3 (335 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cibles associées (non humaines)
Adora2b Adenosine A2 receptor (1828 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mécanismes d'action
Certificats (CoA, COO, BSE/TSE et tableau d'analyse)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Sécurité et dangers (GHS)
Reaxys
9675454
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=9675454&ln=
Calculateurs de solution
Avis

Avis des clients

Application Protocols

No validated, item-specific protocols are provided in this listing.

General workflow suggestions for small-molecule screening (not item-specific):

  • Stock preparation: Dissolve in anhydrous DMSO to a convenient concentration (e.g., 10–50 mM). Vortex, sonicate, and warm mildly if needed. Filter through 0.22 µm PTFE if particulate remains. Record exact concentration by weight-in or quantitative NMR if critical.
  • Plate handling: Dispense with acoustic or pin tools to minimize DMSO carryover; backfill wells to normalize solvent concentration across the plate.
  • Assay execution: Include vehicle controls, concentration-response curves (≥8 points, 3-fold serial dilutions), and orthogonal assay formats to confirm activity.
  • Data integrity: Monitor for aggregation (detergent controls), redox cycling (coupled-enzyme counterscreens), and fluorescence/absorbance interference where relevant.

Item-specific recommended dilutions, incubation times, and positive controls: Not specified for this item; refer to CoA/Spec Sheet and develop assay-specific SOPs.

Biological Roles
  • Endogenous/physiological role: None known; AS100 is supplied as a synthetic small molecule for research use only. No biological function is assigned in this listing.

Research-facing context (general; not item-specific):

  • Screening ligands are often explored as chemical probes to perturb or report on biological pathways. Definitive roles (e.g., enzyme modulation, receptor interaction) require target identification and validation (biochemical potency, selectivity profiling, and mechanistic assays).
  • ADME-relevant properties (permeability, metabolic stability, protein binding) are key to interpreting cellular data; however, such parameters for AS100 are not provided here and must be determined empirically if needed.
  • Off-target risk: Unknown. Apply orthogonal assays and counterscreens to deconvolute assay interference (e.g., redox cycling, PAINS motifs, aggregation). Use detergent controls, dynamic light scattering, and redox-cycling counterscreens as appropriate.

Item-specific data absent:

  • Target class, pathway, and known interactions: Not specified for this item; refer to CoA/Spec Sheet or associated publications if available.

All use is for laboratory research only. No medical, diagnostic, or therapeutic use is implied.

Buffer Applications

AS100 is not a buffering agent and does not constitute a buffer system.

Practical notes for assay buffers (general guidance only):

  • When dosing small-molecule stocks into assay buffers, maintain DMSO at minimal final concentrations compatible with your system (commonly ≤0.5–1% v/v for cells; ≤2–5% v/v for many biochemical assays).
  • Use well-characterized biological buffers (e.g., PBS, HEPES, Tris) tailored to the assay pH and ionic strength. Include surfactant (e.g., 0.01–0.05% Tween-20) if aggregation is suspected.
  • Pre-equilibrate compound with protein/target in buffer containing consistent organic cosolvent to avoid precipitation upon dilution.

Item-specific buffer behavior (solubility windows, pKa, stability): Not specified for this item; refer to CoA/Spec Sheet and verify experimentally.

Green Alternatives

Because AS100 is a discrete small molecule rather than a commodity solvent or reagent, “green alternative” considerations are less about substituting the compound itself and more about optimizing the surrounding workflow.

Greener workflow options (general guidance):

  • Solvent selection: Favor water or water-miscible, lower-toxicity solvents where compatible (e.g., ethanol, isopropanol, acetone) and minimize use of DMF, NMP, or halogenated solvents. Maintain DMSO concentrations in assays at the lowest feasible levels (commonly ≤0.5–1% v/v).
  • Micro-scale operations: Conduct screening and optimization in miniaturized formats (384/1536-well) to cut solvent and material consumption.
  • Energy efficiency: Use ambient-temperature operations when stability allows; avoid prolonged heating of DMSO or DMF solutions.
  • Waste management: Segregate halogenated from non-halogenated waste; employ LC-MS “green” mobile phases (e.g., water–ethanol or water–acetone systems) when method performance permits.

Tradeoffs:

  • Replacing strong dipolar aprotics (DMF/NMP) with greener options can reduce solubility for some hydrophobic ligands; a small percentage of DMSO as cosolvent often restores performance.
  • Switching from acetonitrile to ethanol in LC methods increases viscosity/backpressure and may impact selectivity; method redevelopment may be required.

Note: No item-specific environmental or safety attributes are provided for AS100. For life-cycle or solvent-impact assessments, consult your institutional green-chemistry guidelines.

Pharmaceutical Uses

No pharmacopeial status or excipient role is indicated for this product.

  • Regulatory status: Research use only. Not for human or veterinary use. Not a drug substance, API, or excipient per this listing.
  • Formulation context (general, non-clinical research): For exploratory in vitro studies, compounds are commonly handled as DMSO stocks and diluted into assay medium. For any in vivo-adjacent research conducted under institutional approvals, rigorous characterization (identity, purity, stability, endotoxin where relevant) is required; these data are not provided here.

Item-specific data not provided:

  • Compendial compliance (USP/Ph. Eur., JP): Not specified for this item; refer to CoA/Spec Sheet.
  • Residual solvents, elemental impurities, bioburden/endotoxin, and stability-indicating methods: Not specified for this item; refer to CoA/Spec Sheet.

Note: Aladdin Scientific supplies this material strictly for research use. No therapeutic claims are made or implied.

Physical Properties

Item-specific physico-chemical data are not disclosed in this listing.

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point, boiling point, density, refractive index: Not specified for this item; refer to CoA/Spec Sheet.
  • LogP/logD, pKa, HBD/HBA count, PSA: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.

General/literature guidance for small-molecule screening compounds (not item-specific):

  • Many library ligands are solid organics with MW 200–600 g/mol and are stocked as DMSO solutions (e.g., 10–50 mM) for assay convenience.
  • Solubility is often favorable in DMSO, DMF, or acetonitrile; aqueous solubility depends on ionizable groups and salt form.
  • If hygroscopicity or polymorphism is suspected, verify by Karl Fischer and DSC/XRPD respectively (as applicable).

Important: Do not treat any general values as specifications. For exact physical properties of AS100 (CAS 860033-28-9), consult the product’s CoA/Spec Sheet or request detailed characterization.

Quality and Grades
  • Grade/Purity: Moligand™ (as provided).

What Moligand™ implies (general description; consult CoA for specifics):

  • The Moligand™ designation is used for small-molecule ligands suitable for screening, target engagement studies, and chemical biology probe development. It typically emphasizes identity confirmation and suitability for discovery workflows, rather than chromatographic solvent grades or bioburden specifications.
  • Typical quality controls for such materials include structure confirmation (e.g., NMR, HRMS), purity assessment (e.g., HPLC/UPLC area%), and verification of salt form/solvate content. Exact tests and acceptance criteria are batch-specific.

Item-specific clarifications:

  • Exact purity percentage, residual solvent limits, water content, and elemental/mass balance: Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers/inhibitors: Not specified for this item; refer to CoA/Spec Sheet.

Practical guidance:

  • For screening use, confirm purity and identity thresholds fit your campaign (commonly ≥95% by HPLC area for primary screening; higher for mechanistic biophysics or in vivo-adjacent research).
  • Request orthogonal purity methods if UV chromophores are weak.
  • If working in fragment-based contexts, ensure accurate concentration by quantitative NMR or UV if applicable.
Reaction and Applications

This product is positioned as a Moligand™ screening small molecule rather than a general synthetic reagent. Consequently, it is typically used in discovery workflows rather than as a stoichiometric reactant.

Applications in discovery (general, not item-specific):

  • Primary/secondary screening: Evaluate activity in biochemical, biophysical (e.g., DSF, TSA, MST, ITC), or cell-based assays.
  • Target engagement: CETSA, DARTS, or NanoBRET target engagement assays using DMSO stocks.
  • SAR development: Use the AS100 scaffold (structure required) to guide analog design; pair with orthogonal analytics (LC-MS, NMR) for metabolite ID.
  • Affinity selection and chemoproteomics: If amenable, derivatize to a handle-bearing probe for pulldown/MS identification; confirm binding specificity through competition.

If used synthetically (only if structure supports it):

  • Without the disclosed functional groups, reaction families (e.g., cross-coupling, amide formation) cannot be specified. Consult the structure and literature precedent for feasible transformations.

Important: No manufacturer “Applications” text beyond research-use context was provided in the listing. For project fit, request structural information, purity, and stability data, and run a solubility/stability pre-screen in your assay matrix.

Reaction Conditions

This section generally catalogs reaction conditions for reagents or building blocks. AS100 is a Moligand™ screening compound and is not primarily intended as a reagent.

  • Named reactions, catalysts, temperature ranges, and yields cannot be recommended without knowledge of the functional groups present in AS100.

General guidance if modifications are pursued (not item-specific):

  • Stock solutions: Prepare at 10–50 mM in dry DMSO; protect from moisture and light if the chemotype is sensitive (unknown here).
  • Coupling chemistry: Standard peptide/amide couplings (HATU/EDC) or cross-couplings (Pd-catalyzed) may be applicable if the scaffold bears suitable handles.
  • Stability checks: Monitor by LC-MS before/after reaction; evaluate for decomposition in base/acid, oxidative conditions, or under light.

Item-specific reaction parameters: Not specified for this item; refer to CoA/Spec Sheet and structure.

Safety and Handling

Hazard and GHS details are not provided in this listing and may vary with batch and form.

  • GHS Classification: Not specified for this item; refer to SDS.
  • Signal Word / Hazard (H) Statements / Pictograms: Not specified for this item; refer to SDS.

General laboratory handling guidance for research small molecules (not item-specific; defer to SDS):

  • PPE: Wear lab coat, safety glasses, and suitable gloves (e.g., nitrile). Use in a fume hood to avoid inhalation of dust or vapors.
  • Avoid contact with skin and eyes; prevent ingestion and inhalation. Wash thoroughly after handling.
  • Incompatibilities: Until structure is known, segregate from strong oxidizers, strong acids/bases, and reducing agents. Avoid excessive heat and direct light.
  • Spill/accidental release: Contain solids with inert absorbent; for solutions, absorb with suitable material. Dispose as hazardous chemical waste.
  • First aid (overview): If inhaled, move to fresh air. If skin contact, wash with soap and water. If eye contact, rinse cautiously with water for several minutes. If ingested, rinse mouth; do not induce vomiting; seek medical attention. Always follow the SDS for definitive instructions.

Special risks (general):

  • Unknown dust explosivity and sensitization potential—minimize dust generation and evaluate on small scale first.
  • For DMSO stock solutions, note DMSO can facilitate dermal absorption; maintain strict PPE discipline.

Authoritative safety information must come from the product-specific SDS.

Solvent Selection

Item-specific solubility data are not provided. The following guidance reflects common practice for small-molecule ligands and should be validated experimentally for AS100.

  • Primary stock solvent: DMSO is generally preferred due to broad solvency and assay compatibility. Begin with 10–50 mM trial stocks at room temperature; sonication and gentle warming (≤40°C) can assist dissolution.
  • Secondary solvents for characterization or synthesis: DMF, NMP, acetonitrile, methanol, ethanol, isopropanol, ethyl acetate, dichloromethane, THF. Choose based on polarity and stability of the compound.
  • Aqueous work: If ionizable groups are present, aqueous solubility can be improved via pH adjustment or by preparing a suitable salt. Use co-solvent systems (e.g., 2–10% DMSO or 10–30% acetonitrile) for assay buffers when compatible.
  • Dielectric constants/logP: Not specified for this item; refer to CoA/Spec Sheet or compute from the actual structure.

Comparison (general):

  • DMSO vs DMF: DMSO is typically more biocompatible in assays; DMF is useful for challenging solids but is often less favored in biological contexts.
  • Acetonitrile vs methanol: ACN offers lower viscosity and UV cut-off advantages for analytics; MeOH can be preferable for LC-MS ionization of polar analytes.

Tips:

  • Filter stock solutions (0.22 µm PTFE) if particulate persists.
  • Validate stability in chosen solvent over intended storage/assay durations (freeze–thaw tolerance, hydrolysis risk, precipitation upon dilution).
Storage and Reconstitution
  • Storage Conditions: Store at -20°C (as provided). Maintain in a desiccated, light-protected environment where possible.
  • Shipping: Shipped in an ice chest with ice pads (as provided) to preserve integrity during transit.

Reconstitution (general guidance; not item-specific):

  • Solvent: Use anhydrous DMSO for primary stocks unless item-specific solubility dictates otherwise. Start at 10–50 mM and adjust based on solubility and assay needs.
  • Technique: Allow vial to equilibrate to room temperature before opening to minimize moisture condensation. Weigh quickly, cap promptly, and purge headspace with inert gas if long-term storage is planned.
  • Aliquoting: Prepare single-use aliquots to avoid repeated freeze–thaw. Store aliquots at -20°C to -80°C per your lab’s practice.
  • Stability: Evaluate stability in stock solvent and in assay buffer (precipitation, hydrolysis, oxidation) by LC-MS/UPLC. Protect from light if chromophore-sensitive.

Item-specific details not provided:

  • Exact solubility limits, hygroscopicity, photostability, and recommended long-term storage solvent: Not specified for this item; refer to CoA/Spec Sheet.

Research Use Note: For research use only (as provided).

Structure and Identity

This item is supplied as a Moligand-class small molecule intended for screening and discovery workflows. Item-specific identifiers are limited in the current listing.

  • SKU: A607750; Product Name: AS100
  • CAS: 860033-28-9 (as provided)
  • CID: 135489238 (as provided)
  • InChIKey: 256036 (as provided; note: this appears abbreviated relative to the typical 27-character InChIKey format)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features (general guidance):

  • Without a disclosed structure, ring systems, functional groups, and stereochemistry cannot be itemized. Request the structure or full CoA to assess aromaticity, heteroatom content, hydrogen-bond donors/acceptors, and chiral centers.

2D description (general):

  • As a Moligand screening compound, the structure is typically a discrete, drug-like organic small molecule amenable to dissolution in polar aprotic solvents (e.g., DMSO) for bioassay or binding studies. Exact topology and functional group distribution are not provided in this listing.
Synthetic Utility

AS100 is offered as a Moligand™ small-molecule screening compound and is not primarily positioned as a synthetic building block.

  • Without a disclosed structure, we cannot describe functional groups, protecting-group strategies, or named-reaction compatibility specific to AS100.

General considerations if derivatization is contemplated (structure-dependent; not item-specific):

  • Probe development: If the scaffold contains aniline, phenol, or carboxylate/amine handles, it may be derivatized to biotinylated, alkyne/azide-clickable, or photoaffinity probes for chemoproteomics.
  • SAR expansion: Identify vectors on the core that tolerate substitution; apply robust transformations (amide coupling, Suzuki–Miyaura, Buchwald–Hartwig, reductive amination) if the corresponding handles exist.
  • IP strategy: Before extensive analoging, evaluate literature/prior art around CAS 860033-28-9 (structure required) and confirm freedom to operate.

Conclusion: For concrete synthetic plans, the full molecular structure and analytical package are required. Please request the structure and CoA to assess synthetic tractability.

Target Specificity

No target specificity or biological target class is provided for AS100 in this listing.

  • Antigen/epitope, species reactivity, clone/isotype (for biologics) are not applicable to this small-molecule product.
  • Known targets, selectivity profiles, and off-target panels: Not specified for this item; refer to CoA/Spec Sheet or any associated publications.

Recommendation:

  • If AS100 is used in target identification, pair activity assays with chemoproteomic or biophysical methods to establish on-target engagement and selectivity (competition assays, orthogonal readouts).

All use is for research only.

Besoin d'aide pour choisir la qualité ?

Notre guide de sélection des qualités couvre la pureté, le statut du stabilisant et l'adéquation à l'application pour toutes les variantes de notre catalogue.

Voir le guide des qualités Moligand™ →

Souhaitez-vous que nous vous envoyions un message lorsque des réductions seront disponibles?

Me rappeler plus tard

Merci ! Veuillez vérifier votre boîte de réception e-mail pour confirmer.

Oups ! Les notifications sont désactivées.